Fidelity Investments’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q2 | – | Sell |
-60,565
| Closed | -$509K | – | 2775 |
|
2018
Q1 | $509K | Buy |
60,565
+225
| +0.4% | +$1.89K | ﹤0.01% | 2513 |
|
2017
Q4 | $560K | Sell |
60,340
-52,623
| -47% | -$488K | ﹤0.01% | 2511 |
|
2017
Q3 | $1.32M | Sell |
112,963
-421,502
| -79% | -$4.93M | ﹤0.01% | 2386 |
|
2017
Q2 | $22.3M | Buy |
534,465
+114
| +0% | +$4.76K | ﹤0.01% | 1635 |
|
2017
Q1 | $26M | Buy |
534,351
+2,322
| +0.4% | +$113K | ﹤0.01% | 1583 |
|
2016
Q4 | $17.5M | Hold |
532,029
| – | – | ﹤0.01% | 1733 |
|
2016
Q3 | $21.8M | Buy |
532,029
+1,524
| +0.3% | +$62.4K | ﹤0.01% | 1636 |
|
2016
Q2 | $17.4M | Buy |
530,505
+2,644
| +0.5% | +$86.7K | ﹤0.01% | 1742 |
|
2016
Q1 | $32.7M | Buy |
527,861
+704
| +0.1% | +$43.6K | ﹤0.01% | 1430 |
|
2015
Q4 | $22.2M | Buy |
527,157
+1,027
| +0.2% | +$43.3K | ﹤0.01% | 1643 |
|
2015
Q3 | $28.8M | Buy |
526,130
+73,326
| +16% | +$4.02M | ﹤0.01% | 1498 |
|
2015
Q2 | $49.7M | Buy |
452,804
+15,799
| +4% | +$1.74M | 0.01% | 1340 |
|
2015
Q1 | $41.5M | Buy |
437,005
+106,815
| +32% | +$10.1M | 0.01% | 1416 |
|
2014
Q4 | $18.5M | Buy |
330,190
+3,775
| +1% | +$211K | ﹤0.01% | 1770 |
|
2014
Q3 | $23.6M | Buy |
326,415
+1,582
| +0.5% | +$115K | ﹤0.01% | 1669 |
|
2014
Q2 | $48.7M | Buy |
324,833
+116,041
| +56% | +$17.4M | 0.01% | 1349 |
|
2014
Q1 | $30.4M | Buy |
+208,792
| New | +$30.4M | ﹤0.01% | 1569 |
|